These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7454937)

  • 21. The efficacy and use of anticonvulsants in mood disorders.
    Dunn RT; Frye MS; Kimbrell TA; Denicoff KD; Leverich GS; Post RM
    Clin Neuropharmacol; 1998; 21(4):215-35. PubMed ID: 9704164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological factors in affective disorders and their relevance to lithium prophylaxis.
    Mendlewicz J
    Pharmacopsychiatria; 1982 Jan; 15(1):11-8. PubMed ID: 7063525
    [No Abstract]   [Full Text] [Related]  

  • 23. Who responds to prophylactic lithium therapy?
    Abou-Saleh MT
    Br J Psychiatry Suppl; 1993 Sep; (21):20-6. PubMed ID: 8217063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lithium in the prophylaxis of affective disorders: a twenty years experience.
    Hanus H; Zapletálek M; Kindernayová H; Tůma I
    Act Nerv Super (Praha); 1989 Apr; 31(1):27. PubMed ID: 2781994
    [No Abstract]   [Full Text] [Related]  

  • 26. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium in steroid-induced depression.
    Lynn DJ
    Br J Psychiatry; 1995 Feb; 166(2):264. PubMed ID: 7794382
    [No Abstract]   [Full Text] [Related]  

  • 28. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced plasma cyclic AMP level during prophylactic lithium treatment in patients with affective disorders.
    Arató M; Rihmer Z; Felszeghy K
    Biol Psychiatry; 1980 Apr; 15(2):319-22. PubMed ID: 6251928
    [No Abstract]   [Full Text] [Related]  

  • 30. Computerized documentation for lithium outpatients (routine and research data).
    Simhandl C; Thau K; Wolf R; Lenz G; Lovrek A; Wancata J; Topitz A; Denk E
    Pharmacopsychiatry; 1989 Mar; 22(2):76-80. PubMed ID: 2717660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients].
    Lemke MR; Stuhlmann W
    Psychiatr Prax; 1994 Jul; 21(4):147-50. PubMed ID: 7938323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of action of lithium in affective disorders: a status report.
    Waldmeier PC
    Pharmacol Toxicol; 1990; 66 Suppl 3():121-32. PubMed ID: 2179927
    [No Abstract]   [Full Text] [Related]  

  • 33. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection.
    Grof P; Alda M; Grof E; Fox D; Cameron P
    Br J Psychiatry Suppl; 1993 Sep; (21):16-9. PubMed ID: 8217062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-year follow-up of thyroid function during lithium treatment.
    Bocchetta A; Cherchi A; Loviselli A; Mossa P; Velluzzi F; Derai R; Del Zompo M
    Acta Psychiatr Scand; 1996 Jul; 94(1):45-8. PubMed ID: 8841676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombocytopenia associated with carbamazepine: case report and review.
    Baciewicz G; Yerevanian BI
    J Clin Psychiatry; 1984 Jul; 45(7):315-6. PubMed ID: 6735991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CSF magnesium in affective disorder: lack of correlation with clinical course of treatment.
    George MS; Rosenstein D; Rubinow DR; Kling MA; Post RM
    Psychiatry Res; 1994 Feb; 51(2):139-46. PubMed ID: 8022948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A clinical study on combined lithium and carbamazepine treatment of major affective disorders].
    Chen CC; Ko WK
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Mar; 3(3):176-81. PubMed ID: 3482282
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical pharmacology of aggressive behavior.
    Sheard MH
    Clin Neuropharmacol; 1984; 7(3):173-83. PubMed ID: 6149018
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of carbamazepine and lithium on remission from affective illness.
    Watkins SE; Callender K; Thomas DR; Tidmarsh SF; Shaw DM
    Br J Psychiatry; 1987 Feb; 150():180-2. PubMed ID: 3115347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine.
    Post RM
    Pharmacopsychiatry; 1990 Jan; 23(1):3-17. PubMed ID: 2179972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.